Daniel Rader
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Diet, Metabolism, and Disease 1
- Diabetes Treatment and Management 1
-
- Frailty in Older Adults 1
- Co-authors
- Anand K. Rohatgi (1 shared paper)Ian J. Neeland (1 shared paper)James A. de Lemos (1 shared paper)Philip W. Shaul (1 shared paper)Ivan S. Yuhanna (1 shared paper)Jarett D. Berry (1 shared paper)Amit Khera (1 shared paper)Colby R. Ayers (1 shared paper)
- Journals
- Journal of the American College of Cardiology (3 papers)New England Journal of Medicine (2 papers)Journal of clinical lipidology (1 paper)Current Opinion in Cardiology (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Daniel Rader
9 papers receiving 1.9k citations
Daniel Rader's Hit Papers
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 729
- Cancer Research 298
- Surgery 885
- Cardiology and Cardiovascular Medicine 314
- Clinical Biochemistry 71
Countries citing papers authored by Daniel Rader
This map shows the geographic impact of Daniel Rader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rader more than expected).
Fields of papers citing papers by Daniel Rader
This network shows the impact of papers produced by Daniel Rader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rader. The network helps show where Daniel Rader may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events Hit paper breakdown → | 2014 | 1164 |
| 2 | Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease Hit paper breakdown → | 2017 | 643 |
| 3 | 2015 | 67 | |
| 4 | 2012 | 13 | |
| 5 | 2015 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2017 | 2 | |
| 8 | The Role of HDL-C in the Management of Atherosclerosis | 2015 | 2 |
| 9 | 2017 | 2 |
About Daniel Rader
Daniel Rader is a scholar working on Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology, Physiology, Organizational Behavior and Human Resource Management and Cancer Research, having authored 9 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (2 papers), Frailty in Older Adults (1 paper), Protease and Inhibitor Mechanisms (1 paper), Diet, Metabolism, and Disease (1 paper), Diabetes Treatment and Management (1 paper), Global Public Health Policies and Epidemiology (1 paper) and Health and Medical Research Impacts (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (729 citations), Cancer Research (298 citations), Surgery (885 citations), Cardiology and Cardiovascular Medicine (314 citations) and Clinical Biochemistry (71 citations). Daniel Rader has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Anand K. Rohatgi, Ian J. Neeland, James A. de Lemos, Philip W. Shaul, Ivan S. Yuhanna, Jarett D. Berry, Amit Khera, Colby R. Ayers, Hasan Khalid Siddiqi and Dániel Kiss. Their work appears in journals such as Journal of the American College of Cardiology, New England Journal of Medicine, Journal of clinical lipidology, Current Opinion in Cardiology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.